JP6203760B2 - 併用療法のための医薬組成物 - Google Patents

併用療法のための医薬組成物 Download PDF

Info

Publication number
JP6203760B2
JP6203760B2 JP2014557034A JP2014557034A JP6203760B2 JP 6203760 B2 JP6203760 B2 JP 6203760B2 JP 2014557034 A JP2014557034 A JP 2014557034A JP 2014557034 A JP2014557034 A JP 2014557034A JP 6203760 B2 JP6203760 B2 JP 6203760B2
Authority
JP
Japan
Prior art keywords
tesofensin
obesity
metoprolol
medicament according
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2014557034A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015508765A (ja
JP2015508765A5 (enExample
Inventor
ヘンリク・ビャアク・ハンセン
モルテン・グルネット
ボー・ヨート・ベンツェン
ラース・ヒューヴェレド−ニールセン
ヤアアン・ブース・ラッセン
クラウス・ソングレーン
Original Assignee
サニオナ・エー／エス
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by サニオナ・エー／エス filed Critical サニオナ・エー／エス
Publication of JP2015508765A publication Critical patent/JP2015508765A/ja
Publication of JP2015508765A5 publication Critical patent/JP2015508765A5/ja
Application granted granted Critical
Publication of JP6203760B2 publication Critical patent/JP6203760B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2014557034A 2012-02-16 2013-02-14 併用療法のための医薬組成物 Active JP6203760B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261599623P 2012-02-16 2012-02-16
US61/599,623 2012-02-16
DKPA201270076 2012-02-16
DKPA201270076 2012-02-16
PCT/EP2013/052941 WO2013120935A1 (en) 2012-02-16 2013-02-14 Pharmaceutical compositions for combination therapy

Publications (3)

Publication Number Publication Date
JP2015508765A JP2015508765A (ja) 2015-03-23
JP2015508765A5 JP2015508765A5 (enExample) 2016-03-31
JP6203760B2 true JP6203760B2 (ja) 2017-09-27

Family

ID=48983571

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014557034A Active JP6203760B2 (ja) 2012-02-16 2013-02-14 併用療法のための医薬組成物

Country Status (14)

Country Link
US (5) US9211271B2 (enExample)
EP (1) EP2814473B1 (enExample)
JP (1) JP6203760B2 (enExample)
CN (3) CN108434129A (enExample)
AU (1) AU2013220424B2 (enExample)
CA (1) CA2864264C (enExample)
DK (1) DK2814473T3 (enExample)
EA (1) EA029543B1 (enExample)
ES (1) ES2704987T3 (enExample)
HR (1) HRP20190050T1 (enExample)
LT (1) LT2814473T (enExample)
PL (1) PL2814473T3 (enExample)
SI (1) SI2814473T1 (enExample)
WO (1) WO2013120935A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA029543B1 (ru) * 2012-02-16 2018-04-30 Саниона А/С Способ лечения, профилактики или уменьшения сердечно-сосудистых побочных эффектов тезофенсина
EP3087798A4 (en) * 2013-12-28 2017-08-30 Intel Corporation System and method for device action and configuration based on user context detection from sensors in peripheral devices
HUE055974T2 (hu) 2015-03-03 2022-01-28 Saniona As Tesofensine és metoprolol kombinációs készítmény
US20190060301A1 (en) 2016-01-15 2019-02-28 Saniona A/S Tesofensine and metoprolol for treatment of hypertension
KR20190050784A (ko) 2016-09-07 2019-05-13 사니오나 에이/에스 테소펜신 조성물
WO2020144146A1 (en) 2019-01-07 2020-07-16 Saniona A/S Tesofensine for reduction of body weight in prader-willi patients
CN110297826B (zh) * 2019-05-31 2020-12-11 南京理工大学 基于json动态解析卫星遥测数据的方法
MX2022013236A (es) 2020-04-22 2023-01-24 Saniona As Tratamiento de la obesidad hipotalamica.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2106494A1 (en) 1991-03-18 1992-09-19 James W. Young Composition and method containing optically pure (s) metoprolol
ZA971525B (en) 1996-02-22 1997-10-21 Neurosearch As Tropane derivatives, their preparation and use.
CA2553649A1 (en) 2004-01-22 2005-08-04 Neurosearch A/S Compounds for the sustained reduction of body weight
WO2009065845A1 (en) 2007-11-20 2009-05-28 Neurosearch A/S A method for treating over-eating disorders
US20100317572A1 (en) 2007-12-20 2010-12-16 Neurosearch A/S Pharmaceutical composition comprising tesofensine or its analogue and an anti-obesity compound
WO2009080693A2 (en) * 2007-12-20 2009-07-02 Neurosearch A/S Pharmaceutical composition comprising tesofensine or its analogue and a beta blocker
US9408837B2 (en) 2008-05-28 2016-08-09 Kitov Pharmaceutical Ltd. Ameliorating drug-induced elevations in blood pressure by adjunctive use of antihypertensive drugs
EA029543B1 (ru) * 2012-02-16 2018-04-30 Саниона А/С Способ лечения, профилактики или уменьшения сердечно-сосудистых побочных эффектов тезофенсина
HUE055974T2 (hu) * 2015-03-03 2022-01-28 Saniona As Tesofensine és metoprolol kombinációs készítmény

Also Published As

Publication number Publication date
US20160074344A1 (en) 2016-03-17
US9387184B2 (en) 2016-07-12
JP2015508765A (ja) 2015-03-23
EP2814473A1 (en) 2014-12-24
CN108434129A (zh) 2018-08-24
WO2013120935A1 (en) 2013-08-22
PL2814473T3 (pl) 2019-06-28
US20220016055A1 (en) 2022-01-20
EA201491532A1 (ru) 2015-01-30
LT2814473T (lt) 2019-01-25
US20170007557A1 (en) 2017-01-12
US20180185304A1 (en) 2018-07-05
US9211271B2 (en) 2015-12-15
CN108853071A (zh) 2018-11-23
ES2704987T3 (es) 2019-03-21
SI2814473T1 (sl) 2019-03-29
EA029543B1 (ru) 2018-04-30
EP2814473B1 (en) 2018-10-10
CN104244935A (zh) 2014-12-24
CA2864264C (en) 2020-05-05
US20150025107A1 (en) 2015-01-22
DK2814473T3 (en) 2019-01-28
AU2013220424B2 (en) 2017-03-23
CA2864264A1 (en) 2013-08-22
HK1204946A1 (en) 2015-12-11
AU2013220424A1 (en) 2014-09-25
HRP20190050T1 (hr) 2019-03-08

Similar Documents

Publication Publication Date Title
US20220016055A1 (en) Pharmaceutical Compositions For Combination Therapy
US11000519B2 (en) Pridopidine for treating drug induced dyskinesias
JP6858716B2 (ja) 心筋ミオシン活性化剤と洞房結節Ｉｆ電流阻害剤の併用療法
JP5796959B2 (ja) 関節炎における痛みの治療のためのタペンタドール
PT2701693T (pt) Tapentadol para prevenção e tratamento de depressão e ansiedade
US20160256449A1 (en) H3 receptor antagonist for use in the treatment of alzheimer's disease
JP2007519646A (ja) 体重の持続的低減のための化合物
US12036213B2 (en) Pridopidine for treating drug induced dyskinesias
JP5978472B2 (ja) 耳鳴患者の治療用の薬剤
HK1204946B (en) Pharmaceutical compositions for combination therapy
WO2009080693A2 (en) Pharmaceutical composition comprising tesofensine or its analogue and a beta blocker
JP5978471B2 (ja) 耳鳴患者の治療用の薬剤
KR20220108123A (ko) 치매 환자의 행동 및 심리적 증상 치료

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160210

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160210

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20161107

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170206

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20170207

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170403

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20170406

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20170406

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170630

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20170807

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20170830

R150 Certificate of patent or registration of utility model

Ref document number: 6203760

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350